Form 4: Select Medical Director William Frist Acquires Shares Through Restricted Stock Grants

Select Medical Holdings Corp. Director William H. Frist acquired 15,298 shares of common stock through restricted stock grants on July 29, 2025, increasing his beneficial ownership to 302,797 shares.

Summary

• William H. Frist, a Director and 10% Owner of Select Medical Holdings Corp. (SEM), acquired 15,298 shares of common stock on July 29, 2025.
• One grant involved 1,263 shares acquired at a price of $14.25 per share, issued in lieu of a quarterly retainer of $18,000 under the 2020 Equity Incentive Plan.
• A second grant involved 14,035 shares acquired at a price of $0, which will vest in full on July 29, 2026.
• Following these transactions, Frist's total beneficial ownership of Select Medical common stock increased to 302,797 shares.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates a director's continued commitment to the company through increased equity ownership, aligning their interests with shareholders. It's a routine compensation event, not a major strategic announcement, hence not highly positive.

Positives

• Increased alignment of a director's interests with shareholders through additional equity ownership.
• The issuance of restricted stock in lieu of cash retainer demonstrates a commitment to the company's long-term performance.

Risks

• The value of the restricted stock grants is subject to the future performance of Select Medical's stock price.
• The second grant of 14,035 shares is subject to a one-year vesting period, meaning the shares are not fully owned until July 29, 2026.

Future Outlook

No forward-looking statements or guidance are provided in this transactional filing.

Industry Context

This Form 4 filing details a routine compensation-related equity grant to a director, which is a common practice across various industries to align executive and board interests with shareholder value. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• The practice of granting restricted stock to directors as part of their compensation, including in lieu of cash retainers, is a standard corporate governance practice across publicly traded companies in the healthcare services sector and beyond.
• While specific comparable companies or projects are not mentioned in the filing, this method of compensation is widely adopted by peers to incentivize long-term performance and align interests.
• The vesting schedule for the larger grant (one year) is also a common structure for such awards.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by William H. Frist, a Director and 10% Owner of Select Medical Holdings Corp., constitutes a related party transaction as it involves a transaction between the company and an insider.

Stakeholder Impact

• Shareholders: Increased alignment of a key director's interests with shareholders due to higher equity ownership.

Next Steps

• The 14,035 restricted stock grant will vest on July 29, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving restricted stock grants to a director as part of their compensation. It does not contain information that would fundamentally alter the investment thesis for Select Medical Holdings Corp. While the increased insider ownership is a minor positive for alignment, it's not a catalyst for a 'buy' or 'sell' recommendation. Investors should continue to hold based on the company's broader financial performance and strategic outlook, not solely on this compensation-related filing.

Keywords

Select Medical Holdings Corp, SEM, Form 4, Insider Trading, Restricted Stock, Equity Incentive Plan, Director Compensation, Stock Grant, Beneficial Ownership